The authors acknowledged these mechanistic differences between previous in vitro findings and their in vivo findings, suggesting that the elusive melatonin-induced anti-angiogenic mechanism might induce tumor hypoxia, possibly stimulating activation of Akt and expression of HIF-1α in the LNCaP-xenografted mice. The gene discussed is HIF1A; the disease is neoplasm.